| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $64.0M | +17.0% |
| Cost of Revenue | $14.0M | +8.0% |
| Gross Profit | $50.0M | +19.8% |
| R&D Expense | $996K | +51.8% |
| SG&A Expense | $39.3M | +14.0% |
| Operating Income | $9.7M | +46.8% |
| Pre-tax Income | $10.3M | +46.2% |
| Income Tax | $2.7M | +45.7% |
| Net Income | $7.5M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.3M | -4.9% |
| Accounts Receivable | $24.7M | +5.7% |
| Inventory | $3.3M | -11.1% |
| Current Assets | $45.1M | +2.1% |
| Total Assets | $53.8M | +3.0% |
| Current Liabilities | $10.5M | +36.4% |
| Total Liabilities | $10.6M | +37.8% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $11.4M | +25.7% |
| Capital Expenditures | $262K | -8.7% |
| Investing Cash Flow | -$306K | +22.5% |
| Financing Cash Flow | -$11.9M | — |
| Free Cash Flow | $11.1M | +26.8% |
| +46.3% |
| EPS (Basic) | $0.89 | +48.3% |
| EPS (Diluted) | $0.85 | +46.6% |
| Stockholders' Equity |
| $43.2M |
| -3.0% |